The disclosure concerns imidazo[1,2-a]pyrimidine derivatives of formula (I) and isomers and pharmaceutically acceptable salts thereof. Methods for preparing the compounds, pharmaceutical compositions, and methods of treatment also are disclosed.
该披露涉及公式(I)的
咪唑[1,2-a]
嘧啶衍
生物及其同分异构体和药用盐。还披露了制备这些化合物的方法、药物组合物和治疗方法。